Stem Cell Legislation & Policy
Key laws and policies that shaped funding, ethics, and research practice.
Executive Order 13505: Removing Barriers to Responsible Scientific Research Involving Human Stem Cells
The purpose of this order by President Barack Obama was to remove "limitations on scientific inquiry, to expand NIH support for the exploration of human stem cell research, and in so doing to enhance the contribution of America's scientists to important new discoveries and new therapies for the benefit of humankind."
Executive Order: Expanding Approved Stem Cell Lines in Ethically Responsible Ways
On June 20, 2007, President George W. Bush vetoed the Stem Cell Research Enhancement Act. Alongside his veto, he issued an Executive Order promoting alternative, ethically responsible scientific methods—such as reprogramming adult skin cells—to create pluripotent stem cells without the destruction of human embryos.
Stem Cell Research Enhancement Act (H.R. 810)
The Stem Cell Research Enhancement Act (H.R. 810) aimed to expand federal funding for human embryonic stem cell research by allowing the use of stem cells derived from embryos donated from in vitro fertilization clinics. It was vetoed by President George W. Bush on July 19, 2006, who argued it crossed a moral boundary by supporting the destruction of human embryos. The same day, the House failed, 235-193, to override President Bush’s veto, falling short of the two-thirds majority needed to override a presidential veto.
The Dickey-Wicker Amendment
Congress bans the federal funding for research on embryos through the Dickey-Wicker Amendment, named after its sponsors Jay Dickey (R-AR) and Roger Wicker (R-MI).
The California Stem Cell Research and Cures Act (Proposition 71)
The Act makes conducting stem cell research a state constitutional right. It authorizes the sale of general obligation bonds to allocate three billion dollars over a period of ten years to stem cell research and research facilities. Although the funds could be used to finance all kinds of stem cell research, it gives priority to human embryonic stem cell research.
Stem Cell Therapeutic and Research Reauthorization Act of 2025 (H.R. 5160)
Reauthorizes and updates the Stem Cell Therapeutic and Research Act of 2005.
